Studies of the Taiwanese mouse model of severe SMA have also found evidence to suggest that reduced SMN levels impact other developmental processes, including lung, intestine, heart and longitudinal bone growth [23,24,25]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.